Overview
Imatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies.
Imatinib is a targeted tyrosine kinase inhibitor primarily used to treat various blood cancers and specific solid tumors. Its core indication revolves around cancers driven by abnormal cell growth proteins, most notably the Philadelphia chromosome-positive (Ph+) mutation.